Gene · 8650
Papers2,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The "Vesicular Intelligence" Strategy of Blood Cancers. | Genes (Basel) | 2021 | 33805807 | PubTator, text mining | PubMed |
| Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs. | Cells | 2021 | 33804511 | PubTator, text mining | PubMed |
| Methylation multiplicity and its clinical values in cancer. | Expert Rev Mol Med | 2021 | 33787478 | PubTator, text mining | PubMed |
| A new hypothetical model for pancreatic development based on change in the cell division orientation. | Gene | 2021 | 33775847 | PubTator, text mining | PubMed |
| Heart organoids and tissue models for modeling development and disease. | Semin Cell Dev Biol | 2021 | 33775518 | PubTator, text mining | PubMed |
| Development of alternative splicing signature in lung squamous cell carcinoma. | Med Oncol | 2021 | 33772655 | PubTator, text mining | PubMed |
| C-Jun N-terminal kinase (JNK) pathway activation is essential for dental papilla cells polarization. | PLoS One | 2021 | 33770099 | PubTator, text mining | PubMed |
| Linc-KILH potentiates Notch1 signaling through inhibiting KRT19 phosphorylation and promotes the malignancy of hepatocellular carcinoma. | Int J Biol Sci | 2021 | 33767587 | PubTator, text mining | PubMed |
| MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic. | Front Cell Dev Biol | 2021 | 33763422 | PubTator, text mining | PubMed |
| Potential Role of Musashi-2 RNA-Binding Protein in Cancer EMT. | Onco Targets Ther | 2021 | 33762829 | PubTator, text mining | PubMed |
| SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt. | Dev Cell | 2021 | 33761321 | PubTator, text mining | PubMed |
| Msi1 inhibits cervical cancer cell apoptosis by downregulating BAK through AKT signaling. | J Cancer | 2021 | 33758618 | PubTator, text mining | PubMed |
| IFT20 Mediates the Transport of Cell Migration Regulators From the Trans-Golgi Network to the Plasma Membrane in Breast Cancer Cells. | Front Cell Dev Biol | 2021 | 33748116 | PubTator, text mining | PubMed |
| MicroRNA-15a-5p inhibits endometrial carcinoma proliferation, invasion and migration via downregulation of VEGFA and inhibition of the Wnt/β-catenin signaling pathway. | Oncol Lett | 2021 | 33732386 | PubTator, text mining | PubMed |
| Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC). | Oncogenesis | 2021 | 33723247 | PubTator, text mining | PubMed |
| RBM10 Regulates Tumor Apoptosis, Proliferation, and Metastasis. | Front Oncol | 2021 | 33718153 | PubTator, text mining | PubMed |
| DUOX1 in mammalian disease pathophysiology. | J Mol Med (Berl) | 2021 | 33704512 | PubTator, text mining | PubMed |
| Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study. | Oncol Lett | 2021 | 33692861 | PubTator, text mining | PubMed |
| The construction and validation of an RNA binding protein-related prognostic model for bladder cancer. | BMC Cancer | 2021 | 33685397 | PubTator, text mining | PubMed |
| JMJD6 negatively regulates cytosolic RNA induced antiviral signaling by recruiting RNF5 to promote activated IRF3 K48 ubiquitination. | PLoS Pathog | 2021 | 33684176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8650/papers?page=38